Centro de Investigación en Bioingenieria (BIO), Universidad de Ingenieria y Tecnologia-UTEC, Barranco, Lima, Peru.
Facultad de Medicina, Universidad Nacional Autonoma de Mexico-UNAM, Ciudad Universitaria, Coyoacan, Ciudad de Mexico, Mexico.
Int Rev Cell Mol Biol. 2024;388:124-161. doi: 10.1016/bs.ircmb.2024.07.002. Epub 2024 Aug 5.
Chemokines and their receptors are a family of chemotactic cytokines with important functions in the immune response in both health and disease. Their known physiological roles such as the regulation of leukocyte trafficking and the development of immune organs generated great interest when it was found that they were also related to the control of early and late inflammatory stages in the tumor microenvironment. In fact, in breast cancer, an imbalance in the synthesis of chemokines and/or in the expression of their receptors was attributed to be involved in the regulation of disease progression, including invasion and metastasis. Research in this area is progressing rapidly and the development of new agents based on chemokine and chemokine receptor antagonists are emerging as attractive alternative strategies. This chapter provides a snapshot of the different functions reported for chemokines and their receptors with respect to the potential to regulate breast cancer progression.
趋化因子及其受体是一类趋化细胞因子家族,在健康和疾病中的免疫反应中具有重要功能。当发现它们与肿瘤微环境中早期和晚期炎症阶段的控制也有关时,它们已知的生理作用,如白细胞迁移的调节和免疫器官的发育,引起了极大的兴趣。事实上,在乳腺癌中,趋化因子的合成和/或其受体的表达失衡被认为参与了疾病进展的调节,包括侵袭和转移。该领域的研究进展迅速,基于趋化因子和趋化因子受体拮抗剂的新药物的开发正成为一种有吸引力的替代策略。本章提供了趋化因子及其受体的不同功能的快照,这些功能与调节乳腺癌进展的潜力有关。